Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
An independent review of Ro's Better Business Bureau ratings, FDA warning letters, state-board actions, and verified consumer-complaint patterns across GLP-1, ED, hair, and mental-health services.
Read clinical reviewAn independent review of Ro's LegitScript certification, pharmacy accreditation, state board standing, FDA compliance record, BBB ratings, and patient complaint history. Verified primary-source citations throughout.
Read clinical reviewAn independent, evidence-based review of Ro's medical leadership, physician credentials, licensing, compounding practices, and patient safety record. Includes BBB data, FDA warning letters, and state board compliance.
Read clinical reviewAn independent review of Ro telehealth's prescribing patterns, compounding practices, patient outcomes signals, complaint records, and regulatory standing across GLP-1, ED, hair loss, and mental health services.
Read clinical reviewA critical, evidence-based look at Ro's pricing history across GLP-1, ED, hair loss, and mental health programs, including compounding cost shifts, FDA actions, and real patient cost data from 2018 to 2025.
Read clinical reviewA clinical breakdown of which patients should avoid Ro's telehealth platform, covering GLP-1, ED, hair loss, and mental health services, with independent analysis of legitimacy, complaints, and safety concerns.
Read clinical review